UnitedHealthcare to cover Inspire Medical’s sleep apnea therapy

UnitedHealthcare will provide coverage for Inspire Medical Systems’ (NYSE:INSP), Inspire therapy effective August 1, 2019.

Under its policy, UnitedHealthcare considers Inspire’s FDA approved hypoglossal nerve neurostimulation device to be medically necessary for the treatment of moderate to severe obstructive sleep apnea (OSA) when specified criteria are met.

INSP now have 35 coverage policies, representing approx. 125M members.

Shares are up 7% premarket.

https://seekingalpha.com/news/3476153-unitedhealthcare-issues-coverage-inspire-medicals-therapy-osa